Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap

키워드

참고문헌 (14)

1. Shao YY, "Management consensus guideline for hepatocellular carcinoma : 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan", J Formos Med Assoc, 120, pp.1051~1060 (2021)
2. Tung-Hung Su, "Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective", Clinical and Molecular Hepatology, 29(2), pp.230~241 (2023), 대한간학회
3. Won Sohn, "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease", Clinical and Molecular Hepatology, 28(4), pp.851~863 (2022), 대한간학회
4. Bo Hyun Kim, "Surveillance for hepatocellular carcinoma: It is time to move forward", Clinical and Molecular Hepatology, 28(4), pp.810~813 (2022), 대한간학회
5. Jung Hwan Yu, "The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection", Clinical and Molecular Hepatology, 28(3), pp.351~361 (2022), 대한간학회[DOI]
6. Lok AS, "Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma", Gastroenterology, 138, pp.493~502 (2010)
7. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines : Management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
8. Marrero JA, "Diagnosis, staging, and management of hepatocellular carcinoma : 2018 Practice Guidance by the American Association for the Study of Liver Diseases", Hepatology, 68, pp.723~750 (2018)
9. Kierans AS, "The diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm : A meta-analysis", Radiology, 278, pp.82~94 (2016)
10. Kudo M, "Management of hepatocellular carcinoma in Japan : JSH Consensus statements and recommendations 2021 update", Liver Cancer, 10, pp.181~223 (2021)
11. Korean Liver Cancer Association (KLCA), "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Clinical and Molecular Hepatology, 28(4), pp.583~705 (2022), 대한간학회
12. Cheng AL, "Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma", J Hepatol, 72, pp.307~319 (2020)
13. Bruix J, "Systemic treatment of hepatocellular carcinoma : An EASL position paper", J Hepatol, 75, pp.960~974 (2021)
14. Reig M, "BCLC strategy for prognosis prediction and treatment recommendation : The 2022 update", J Hepatol, 76, pp.681~693 (2022)

관련 논문AI추천